| Secondary |
| Product Used For Unknown Indication |
23.1% |
| Drug Use For Unknown Indication |
16.2% |
| Angina Pectoris |
6.4% |
| Hypertension |
6.4% |
| Prophylaxis |
5.2% |
| Dementia Alzheimer's Type |
4.6% |
| Myocardial Infarction |
4.6% |
| Cardiac Failure |
4.0% |
| Ill-defined Disorder |
4.0% |
| Essential Hypertension |
3.5% |
| Arrhythmia |
2.9% |
| Diabetes Mellitus |
2.9% |
| Hypothyroidism |
2.9% |
| Analgesic Therapy |
2.3% |
| Pain |
2.3% |
| Back Pain |
1.7% |
| Deep Vein Thrombosis |
1.7% |
| Gastrooesophageal Reflux Disease |
1.7% |
| Ischaemic Stroke |
1.7% |
| Lung Neoplasm Malignant |
1.7% |
|
| Toxic Skin Eruption |
13.3% |
| Hallucination, Visual |
6.7% |
| Pain In Extremity |
6.7% |
| Shock |
6.7% |
| Somnolence |
6.7% |
| Thrombosis |
6.7% |
| Toxicity To Various Agents |
6.7% |
| Urinary Tract Infection |
6.7% |
| Deep Vein Thrombosis |
3.3% |
| Drug Effect Decreased |
3.3% |
| Haematoma |
3.3% |
| Haematuria |
3.3% |
| Hepatocellular Injury |
3.3% |
| Hiatus Hernia |
3.3% |
| Hyponatraemia |
3.3% |
| International Normalised Ratio Increased |
3.3% |
| Malaise |
3.3% |
| Malnutrition |
3.3% |
| Muscle Rigidity |
3.3% |
| Pallor |
3.3% |
|
| Concomitant |
| Hypertension |
19.1% |
| Product Used For Unknown Indication |
18.6% |
| Dementia Alzheimer's Type |
9.8% |
| Ill-defined Disorder |
9.3% |
| Depression |
3.8% |
| Gout |
3.8% |
| Type 2 Diabetes Mellitus |
3.8% |
| Cardiac Failure |
3.3% |
| Hyperuricaemia |
3.3% |
| Multiple Myeloma |
3.3% |
| Drug Use For Unknown Indication |
2.7% |
| Hypercholesterolaemia |
2.7% |
| Myocardial Infarction |
2.7% |
| Heart Transplant |
2.2% |
| Osteoporosis |
2.2% |
| Prophylaxis |
2.2% |
| Renal Transplant |
2.2% |
| Convulsion |
1.6% |
| Diabetes Mellitus |
1.6% |
| Liver Transplant |
1.6% |
|
| Weight Decreased |
14.9% |
| Renal Failure Acute |
13.4% |
| Vomiting |
9.0% |
| Malaise |
6.0% |
| Shock |
6.0% |
| Agranulocytosis |
4.5% |
| Thrombocytopenia |
4.5% |
| Transaminases Increased |
4.5% |
| Tremor |
4.5% |
| Cardiac Failure |
3.0% |
| Cytolytic Hepatitis |
3.0% |
| Hepatitis |
3.0% |
| International Normalised Ratio Increased |
3.0% |
| Ischaemic Stroke |
3.0% |
| Leukocytosis |
3.0% |
| Melaena |
3.0% |
| Neuralgia |
3.0% |
| Orthostatic Hypotension |
3.0% |
| Overdose |
3.0% |
| Pain In Extremity |
3.0% |
|
